JACQUES BERGMAN
Holanda


Jacques Bergman was born in 1965 and qualified from the University of Utrecht in 1991. He undertook his PhD-training, dedicated to the endoscopic management of gallstone disease, in Amsterdam. He was trained in Gastroenterology in Den Bosch and Amsterdam and was appointed Consultant Gastroenterologist, at Academic Medical Center in Amsterdam in 2001, as Associate Professor in 2005, and as Head of department of Endoscopy and Professor of Gastrointestinal Endoscopy in 2011.
Jacques Bergman leads a variety imaging studies on detection of early neoplasia in the upper GI tract. Techniques that are currently under investigation include high resolution endoscopy, optical chromoscopy, volumetric laser endomicroscopy, and spectroscopy techniques. His group also investigates computer assisted endoscopic detection of early neoplasia as part of a consortium with the Technical University Eindhoven and 15 leading endoscopy centers in Europe.
In addition, his group has a strong focus on the endoscopic treatment of early neoplasia using endoscopic resection and endoscopic ablation techniques as well as in organizing training programs in this field (www.barrett.nl and www.best-academia.eu).
The group also facilitates basic research on biomarkers in Barrett’s esophagus; epithelial differentiation, morphogenesis and pathogenesis in Barrett’s esophagus; gene therapy and dendritic cell therapy for esophageal cancer; and proteomics in Barrett’s esophagus.
Jacques Bergman leads ReBus: a large tissue bank project that incorporates clinical data and tissue samples of 1,000 patients treated for early Barrett‘s neoplasia; 3,500 Barrett‘s surveillance patients in the Amsterdam region; 1,500 proscpectively followed Barrett‘s patients in the Amsterdam Prospective Barrett‘s Registration Project; and 750 Barrett‘s patients with low-grade dysplasia.
Jacques Bergman is also involved in studies investigating the use of duodenal mucosal ablation for metabolic regulation (diabetes mellitus and NAFLD/NASH) in which he collaborates with endocrinologists and hepatologists at the AMC and a number of European institutes.
The team currently consists of two physicians/endoscopists, 18 clinical research fellows, three research nurses, and 2 physician assistants. The group has extensive experience with clinical trials and is trained according to GCP standards. The team coordinates several international multi-center studies.
Dr Bergman is the special section editor of Gastroenterology in Motion of the journal Gastroenterology. He is a member of the International Editorial board of “Gastrointestinal Endoscopy” and member of the International Editorial board of “Endoscopy”.

Dr. Bergman is a permanent member of International Working Group on Classification of Oesophagitis.

Dr. Bergman has authored and co-authored on over 350 peer reviewed publications and text book chapters and has lectured at many national and international meetings. His Hirsch-index is currently 65.